Free Trial
NASDAQ:DBVT

DBV Technologies (DBVT) Stock Price, News & Analysis

DBV Technologies logo
$9.46 -0.03 (-0.31%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About DBV Technologies Stock (NASDAQ:DBVT)

Key Stats

Today's Range
$8.91
$10.34
50-Day Range
$8.51
$11.54
52-Week Range
$2.20
$12.78
Volume
27,790 shs
Average Volume
198,339 shs
Market Capitalization
$258.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.75
Consensus Rating
Moderate Buy

Company Overview

DBV Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

DBVT MarketRank™: 

DBV Technologies scored higher than 68% of companies evaluated by MarketBeat, and ranked 331st out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DBV Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    DBV Technologies has only been the subject of 2 research reports in the past 90 days.

  • Read more about DBV Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for DBV Technologies are expected to grow in the coming year, from ($7.05) to ($5.45) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DBV Technologies is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DBV Technologies is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DBV Technologies has a P/B Ratio of 3.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about DBV Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    0.04% of the float of DBV Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    DBV Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DBV Technologies has recently decreased by 17.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    DBV Technologies does not currently pay a dividend.

  • Dividend Growth

    DBV Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.04% of the float of DBV Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    DBV Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DBV Technologies has recently decreased by 17.73%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    DBV Technologies has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for DBV Technologies this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for DBVT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DBV Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,030.00 in company stock.

  • Percentage Held by Insiders

    Only 1.44% of the stock of DBV Technologies is held by insiders.

  • Percentage Held by Institutions

    71.74% of the stock of DBV Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DBV Technologies' insider trading history.
Receive DBVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DBV Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DBVT Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
See More Headlines

DBVT Stock Analysis - Frequently Asked Questions

DBV Technologies' stock was trading at $3.09 at the beginning of the year. Since then, DBVT stock has increased by 205.5% and is now trading at $9.44.

DBV Technologies S.A. (NASDAQ:DBVT) posted its quarterly earnings data on Tuesday, July, 29th. The company reported ($1.55) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $1.34. The firm had revenue of $1.74 million for the quarter, compared to analysts' expectations of $0.64 million. DBV Technologies had a negative trailing twelve-month return on equity of 287.15% and a negative net margin of 3,220.49%.

DBV Technologies's stock reverse split before market open on Friday, November 29th 2024.The 1-5 reverse split was announced on Monday, November 11th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Top institutional investors of DBV Technologies include Vivo Capital LLC (3.85%), Adage Capital Partners GP L.L.C. (3.85%), MPM Bioimpact LLC (3.85%) and Octagon Capital Advisors LP (3.72%). Insiders that own company stock include Pharis Mohideen, Daniel B Soland, Timothy E Morris and Adora Ndu.
View institutional ownership trends
.

Shares of DBVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DBV Technologies investors own include Meta Platforms (META), Pfizer (PFE), Novavax (NVAX), NVIDIA (NVDA), OPKO Health (OPK), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
7/29/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DBVT
CIK
1613780
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$21.00
Low Price Target
$7.25
Potential Upside/Downside
+50.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$113.92 million
Net Margins
-3,220.49%
Pretax Margin
-3,217.23%
Return on Equity
-287.15%
Return on Assets
-138.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.45
Quick Ratio
2.45

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.15 per share
Price / Book
3.10

Miscellaneous

Outstanding Shares
27,390,000
Free Float
26,996,000
Market Cap
$267.87 million
Optionable
Optionable
Beta
-0.58
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:DBVT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners